rapidli
respond
novel
pathogen
repres
extrem
challeng
complex
endeavor
numer
promis
therapeut
vaccin
research
effort
mitig
catastroph
effect
pandem
underway
yet
efficaci
countermeasur
still
avail
support
global
research
effort
use
novel
comput
pipelin
combin
machin
learn
bioinformat
supercomput
predict
antibodi
structur
capabl
target
receptor
bind
domain
rbd
day
use
sequenc
previous
publish
neutral
antibodi
structur
gener
initi
antibodi
sequenc
predict
target
rbd
first
step
process
predict
publicli
releas
structur
spike
protein
use
homologybas
structur
model
predict
structur
prove
accur
within
target
rbd
region
compar
experiment
deriv
structur
publish
week
later
next
use
silico
design
platform
iter
propos
mutat
neutral
antibodi
known
bind
enabl
optim
bind
within
rbd
start
calcul
baselin
free
energi
kcalmol
select
first
round
antibodi
structur
predict
improv
interact
rbd
free
energi
low
kcalmol
baselin
antibodi
complex
rbd
calcul
interact
energi
kcalmol
neutral
viru
prevent
bind
enter
human
receptor
result
suggest
predict
antibodi
mutant
may
bind
rbd
potenti
neutral
viru
addit
select
antibodi
mutant
score
well
accord
multipl
antibodi
develop
metric
antibodi
design
express
experiment
test
bind
viral
protein
provid
invalu
feedback
improv
machin
learningdriven
design
technic
report
highlevel
descript
effort
supplementari
materi
includ
homologybas
structur
model
develop
silico
free
energi
calcul
mutant
antibodi
deriv
known
neutral
antibodi
biorxiv
preprint
bioinformat
heurist
comput
number
mutat
consid
unlik
label
number
unconvent
mutat
dataset
provid
supplementari
materi
mutant
antibodi
consid
heurist
describ
mutat
low
probabl
mutat
probabl
distribut
deriv
numer
promis
therapeut
vaccin
research
effort
underway
yet
therapeut
vaccin
current
avail
tradit
drug
biolog
develop
experimentdriven
typic
execut
via
largescal
screen
vitro
vivo
tradit
approach
led
mani
effect
safe
therapeut
requir
year
complet
therefor
alon
reli
upon
support
rapid
respons
novel
pathogen
datadriven
machin
learn
method
increasingli
explor
rapid
therapeut
develop
potenti
offer
promis
rapid
design
phase
howev
pure
datadriven
machin
learn
system
would
limit
rapid
respons
scenario
due
inevit
insuffici
avail
data
novel
emerg
pathogen
theorydriven
comput
method
molecular
dynam
simul
provid
virtual
limitless
amount
data
target
system
still
requir
experiment
valid
lawrenc
livermor
nation
laboratori
llnl
glaxosmithklin
gsk
vaccin
research
develop
combin
computationalexperiment
platform
vaccin
antigen
design
last
two
year
combin
platform
combin
experimentdriven
datadriven
theorydriven
approach
leverag
strength
approach
mitig
limit
initi
predict
platform
driven
comput
compon
base
integr
exist
experiment
data
structur
biologybioinformat
model
molecular
dynam
simul
highperform
comput
system
activ
machin
learn
model
aim
optim
bind
behavior
iter
propos
mutat
amino
acid
sequenc
initi
antigen
propos
mutant
antigen
evalu
exist
comput
bind
estim
tool
use
known
estim
antibodyantigen
structur
platform
leverag
featur
represent
threedimension
antigenantibodi
interfac
bayesian
optim
algorithm
propos
comput
evalu
mutant
high
predict
perform
mutant
improv
machin
learn
model
comput
platform
improv
predict
propos
design
evalu
high
throughput
experiment
evalu
compon
result
incorpor
machin
learn
model
feedback
loop
combin
computationalexperiment
antigen
design
platform
result
gener
describ
greater
detail
futur
joint
public
gsk
includ
detail
machin
learn
model
respons
pandem
modifi
use
comput
compon
antigen
design
platform
propos
mutat
neutral
antibodi
achiev
optim
bind
receptor
bind
domain
rbd
spike
protein
approach
motiv
enabl
knowledg
exist
antibodi
specif
rbd
spike
protein
prevent
bind
human
receptor
enter
cell
thu
neutral
viru
high
similar
includ
rbd
suggest
approach
could
produc
efficaci
therapeut
antibodi
day
demonstr
platform
could
gener
antibodi
design
use
sequenc
inform
support
antibodyantigen
structur
previous
experiment
determin
execut
entir
workflow
construct
homologybas
structur
model
experiment
determin
structur
sprotein
avail
absenc
known
spike
protein
structur
character
surfac
glycoprotein
sequenc
construct
homologybas
structur
model
use
protein
model
system
structur
spike
protein
protein
data
bank
pdb
entri
identifi
closest
complet
pdb
structur
templat
use
model
resolut
respect
four
templat
last
three
provid
experiment
solv
complex
three
antibodi
main
focu
construct
homolog
model
achiev
highest
possibl
accuraci
rbdfab
antigenbind
fragment
interfac
use
addit
pdb
templat
refin
model
correspond
region
exampl
pdb
templat
use
improv
accuraci
model
interfac
rbd
fab
neutral
antibodi
cryoemderiv
structur
spike
protein
becam
avail
feb
publicli
releas
feb
http
xray
crystal
structur
receptorbind
domain
becam
avail
start
march
http
publish
comparison
homolog
model
indic
estim
structur
complet
jan
publicli
avail
begin
feb
accur
especi
fab
antigenbind
fragment
antibodi
interfac
figur
tabl
show
residu
deviat
homolog
model
cryoem
structur
structur
use
xray
structur
refer
two
region
indic
rectangular
box
residu
part
loop
region
local
conform
deviat
note
region
part
interfac
select
antibodi
figur
depict
homologybas
model
superimpos
cryoem
structur
antibodi
structur
provid
indic
fabrbd
interfac
region
note
region
deviat
outsid
interfac
region
lga
global
distanc
calcul
gdc
xray
structur
list
descend
order
lga
type
rmsd
sequenc
ident
lga
gdc
detail
computationalexperiment
platform
describ
greater
detail
futur
public
includ
detail
activ
machin
learn
model
featur
space
use
repres
three
dimension
antigenantibodi
interfac
antibodi
optim
pipelin
overal
gener
initi
antibodi
execut
follow
step
obtain
structur
experimentallydetermin
atom
coordin
previous
deposit
pdb
sever
antibodi
complex
sprotein
obtain
sequenc
sprotein
map
public
spike
protein
sequenc
structur
estim
costructur
involv
antibodi
complet
jan
made
publicli
avail
feb
use
two
antibodi
subsequ
calcul
defin
set
residu
modif
start
antibodi
via
automat
contact
estim
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
consid
insert
delet
phase
work
use
machin
learn
modul
comput
design
platform
iter
propos
mutat
origin
antibodi
perform
free
energi
calcul
use
foldx
llnl
highperform
comput
hpc
maxim
estim
affin
spike
protein
homolog
model
feb
evalu
mutant
antibodi
select
design
space
amino
acid
posit
primari
templat
structur
pdb
use
hpc
perform
addit
free
energi
calcul
select
antibodi
sequenc
perform
free
energi
calcul
use
rosetta
antibodi
molecular
dynam
simul
assess
sequenc
statium
energi
predict
tool
complet
feb
assess
develop
select
antibodi
sequenc
use
develop
metric
therapeut
antibodi
profil
use
machin
learn
modul
comput
design
platform
iter
propos
mutat
origin
antibodi
run
foldx
calcul
llnl
hpc
estim
free
energi
spike
protein
homolog
model
foldx
bind
calcul
estim
chang
free
energi
ddg
antibodyantigen
protein
complex
result
propos
mutat
use
calcul
part
object
function
drive
antibodi
optim
via
machin
learn
model
evalu
mutant
foldx
cours
search
improv
antibodi
estim
ddg
valu
rang
kcalmol
figur
plot
improv
foldxestim
ddg
valu
cours
machin
learningdriven
optim
process
result
indic
machin
learn
model
effect
search
combinatori
space
possibl
antibodi
mutant
perform
design
optim
identifi
increasingli
improv
predict
antibodi
design
select
subset
antibodi
mutant
addit
calcul
use
rosetta
statium
molecular
dynam
calcul
well
antibodi
develop
estim
via
therapeut
antibodi
profil
see
method
section
silico
calcul
perform
use
select
first
round
antibodi
molecular
mechanicsgener
born
solvent
access
surfac
area
mmgbsa
molecular
dynam
calcul
describ
method
section
consid
accur
estim
mmgbsa
calcul
antibodyantigen
interact
free
energi
use
fulli
solvat
molecular
dynam
md
conform
sampl
protein
complex
estim
free
energi
comput
less
expens
implicit
solvent
model
gbsa
start
templat
design
known
neutral
bind
rbd
prevent
viru
bind
enter
human
receptor
mmgbsa
calcul
complex
spike
protein
yield
kcalmol
known
bind
spike
protein
yield
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
result
suggest
antibodi
mutant
potenti
bind
neutral
start
jan
use
two
highperform
comput
llnl
cours
day
support
cpu
hour
gpu
hour
perform
silico
free
energi
calcul
candid
antibodi
complex
rbd
perform
work
use
sequenc
previous
publish
neutral
antibodi
structur
predict
structur
prove
accur
within
target
rbd
region
compar
experiment
deriv
structur
publish
week
later
predict
structur
use
silico
design
platform
evalu
mutant
antibodi
iter
propos
mutat
neutral
antibodi
optim
bind
within
rbd
select
initi
antibodi
sequenc
predict
target
rbd
start
baselin
free
energi
kcalmol
select
first
round
antibodi
structur
predict
improv
interact
rbd
free
energi
rang
low
kcalmol
baselin
antibodi
complex
rbd
calcul
free
energi
kcalmol
neutral
viru
prevent
bind
enter
human
receptor
result
suggest
predict
antibodi
mutant
may
bind
rbd
therefor
potenti
neutral
viru
addit
antibodi
mutant
score
well
accord
multipl
antibodi
develop
metric
via
therapeut
antibodi
profil
antibodi
design
express
experiment
test
bind
spike
protein
provid
invalu
feedback
improv
machin
learningdriven
design
also
continu
improv
platform
perform
addit
silico
calcul
includ
futur
updat
document
addit
current
perform
higher
fidel
molecular
dynam
calcul
increas
accuraci
predict
use
investig
bind
hotspot
via
singl
point
mutat
comput
analysi
explor
potenti
impact
glycosyl
rbd
site
supplementari
materi
document
includ
homologybas
structur
model
develop
complex
neutral
antibodi
antibodi
mutant
sequenc
silico
free
energi
calcul
perform
mutant
antibodi
deriv
neutral
antibodi
use
select
first
round
candid
antibodi
experiment
evalu
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
absenc
known
spike
protein
structur
character
surfac
glycoprotein
sequenc
construct
homologybas
structur
model
use
system
assess
region
sequencestructur
conserv
variabl
sequenc
creat
set
initi
structur
model
use
avail
templat
compar
analysi
construct
model
avail
templat
pdb
perform
use
stralsv
algorithm
identifi
protein
fragment
exhibit
structur
similar
despit
low
primari
amino
acid
sequenc
similar
region
structur
conform
uncertainti
observ
use
result
search
model
miss
loop
region
assess
possibl
structur
conform
divers
preliminari
model
construct
final
model
conform
sidechain
atom
predict
use
scwrl
residueresidu
correspond
match
residu
ident
templat
spike
protein
copi
templat
onto
model
structur
stereochem
qualiti
model
check
use
contactdot
algorithm
molprob
softwar
packag
final
construct
model
finish
relax
use
ucsf
chimera
figur
show
two
construct
structur
model
spike
protein
complex
fab
fig
respect
neutral
antibodi
set
provid
model
construct
help
assess
possibl
differ
conform
spikeantibodi
complex
ddg
foldx
calcul
mutant
antibodi
complex
rbd
start
structur
minim
use
minim
structur
procedur
avail
ucsf
chimera
process
follow
iter
repairpdb
function
foldx
perform
ddg
calcul
defin
list
mutat
use
buildmodel
procedur
estim
stabil
dg
defin
free
energi
protein
use
run
procedur
check
calcul
rotam
specifi
mutat
converg
optim
trap
solut
first
set
ddg
estim
calcul
differ
free
energi
dg
mutant
wildtyp
label
foldx
ddg
averag
supplementari
materi
addit
ddg
estim
calcul
use
analysecomplex
algorithm
use
wildtyp
mutat
model
calcul
ddg
base
energi
chang
interfac
within
rbdfab
complex
label
foldx
ddg
interfac
supplementari
materi
estim
ddg
valu
use
rosetta
start
structur
minim
use
relax
procedur
proteinfab
complex
model
made
relax
structur
chose
repres
model
lowest
free
energi
structur
calcul
ddg
estim
chang
stabil
use
ddgmonom
algorithm
iter
set
describ
label
rosetta
ddg
total
energi
supplementari
materi
addit
ddg
estim
calcul
use
flexddg
protocol
evalu
energi
chang
focus
interfac
within
rbdfab
complex
label
rosetta
ddg
flex
supplementari
materi
addit
rosetta
calcul
total
energi
flex
perform
possibl
singlepoint
mutat
locat
select
mutat
amino
acid
mutat
possibl
locat
total
rosetta
singlepoint
mutat
calcul
use
molecular
mechanicsgener
born
solvent
access
surfac
area
mmgbsa
calcul
antibodyantigen
interact
free
energi
mmgbsa
use
fulli
solvat
molecular
dynam
conform
sampl
protein
complex
estim
free
energi
comput
cheaper
implicit
solvent
model
gbsa
molecular
dynam
simul
perform
openmm
toolkit
molecular
simul
use
amber
forc
field
posit
constraint
kcalmol
place
backbon
atom
c
n
ca
heat
system
system
heat
k
increment
ps
temperatur
system
k
constraint
remov
equilibr
perform
ns
ten
individu
ns
dynam
simul
perform
equilibr
system
conform
sampl
last
ns
dynam
ps
increment
simul
use
mmgbsa
calcul
total
structur
mmgbsa
calcul
perform
use
mmpbsapi
part
amber
suit
program
substitut
matrix
mutat
probabl
distribut
give
substitut
higher
probabl
eg
lower
eg
w
total
probabl
destin
amino
acid
given
point
mutat
given
probabl
ie
less
mutat
declar
unconvent
count
increment
one
exampl
alanin
mutat
unconvent
heurist
